Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing ...
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new ...
(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) and its U.S. Unit Genentech announced Tuesday that the U.S. Food and Drug ...
LONDON (dpa-AFX) - Roche (RHHBY) said that it has received CE Mark approval for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx, enabling the identification of metastatic breast ...
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options 1,2 Additional analyses of INAVO120 will be presented in ...
Roche-Aktie schwächelt: Boris Zaïtra ab Juli Pharma Partnering-Chef von Roche Neubesetzung Beim Pharmakonzern Roche kommt es am 1. Juli zu einem Wechsel in der erweiterten Konzernleitung.
Roche-Aktie für 0 € Ordergebühr (zzgl. Spreads) handeln – hier informieren ...